In a decisive pivot toward domestic supply chain security, Swiss contract development and manufacturing organization Siegfried is making a significant move to solidify its foothold in the United States, announcing a series of acquisitions designed to bolster its small-molecule drug substance
A single, microscopic trace of a beta-lactam antibiotic in an unrelated medication can trigger a life-threatening allergic reaction in a susceptible patient, a risk that has reshaped modern pharmaceutical production. The growing significance of segregated manufacturing is a direct response to this
America Makes has officially unveiled a pivotal new initiative designed to bridge the gap between academic theory and practical application, launching its 2026 Additive in Steel Competition to cultivate the next wave of talent in Additive Manufacturing (AM). This forward-thinking challenge calls
A recently unveiled bilateral agreement between Ottawa and Beijing is poised to fundamentally reshape Canada's trade landscape, signaling a deliberate and controversial pivot away from its long-standing economic alignment with the United States. This landmark pact, brokered by Prime Minister Mark
A tectonic shift is reshaping the American pharmaceutical landscape, not through prolonged legislative battles, but through a series of unprecedented voluntary pacts brokered in the shadow of significant economic threats. Facing immense political pressure over medication costs, leading drug
The promise of cell therapy to treat and potentially cure some of the most challenging diseases has long been tempered by a formidable barrier: the immense difficulty of manufacturing these personalized medicines at scale. As a groundbreaking presentation at the Biotech Showcase™ in San Francisco
